Nuformix (LON:NFX) Shares Down 1.1%
Shares of Nuformix PLC (LON:NFX) were down 1.1% on Tuesday . The stock traded as low as GBX 9.03 ($0.12) and last traded at GBX 9.15 ($0.12), approximately 2,298,659 shares traded hands during mid-day trading. An increase of 103% from the average daily volume of 1,130,000 shares. The stock had previously closed at GBX 9.25 ($0.12).
The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 0.38. The firm has a 50-day simple moving average of GBX 8.10 and a two-hundred day simple moving average of GBX 8.30. The company has a market capitalization of $41.56 million and a price-to-earnings ratio of -42.50.
About Nuformix (LON:NFX)
Nuformix plc develops pharmaceutical products using its cocrystal technology in the United Kingdom. Its lead programs include NXP001, which is used for oncology supportive care; and NXP002 for use in the treatment of fibrosis. The company is also developing NXP003, which is under the pre-clinical stage for the treatment of anti-inflammatory diseases.
Recommended Story: Rule of 72
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.